Series C funding round for Boundless Bio raising $100M in May 2023
Series C funding round for Boundless Bio raising $100M in May 2023
| Investor | Firm Type | Partner |
|---|
| Private | — |
Leaps by BayerLEAD | Corporate Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Hedge Fund | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$256M
Top Valuation
-
Boundless Bio raised $100M in a Series C round.
The round was announced on 05/01/23.
The round was led by Fabio Pucci, RA Capital Management.